The present study revealed that low GSTM5 gene expression and high GSTM5 DNA methylation level tended to bladder cancer (Figure 1 and Figure 2D) and that patients with bladder cancer and high GSTM5 expression had a longer relapse-free survival (Figure 2F). This evidence concerns the gene GSTM5 and urinary bladder cancer.